(EN)
The present invention relates to novel sulfamoyl-phenyl-ureido compounds
having the formula (I) or a physiologi-cally
acceptable salt or derivative thereof which are suitable for the therapy of
infections caused by protozoa and in particular un-complicated
or severe malaria caused by plasmodia.